EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Opioid-sparing effect of erector spinae plane block and intravenous dexmedetomidine for obese patients with obstructive sleep apnea: A randomized controlled trial

Mona Raafat Elghamry, Atteia Gad Anwar, Shaimaa Waheed Zahra

Journal of Opioid Management · 2024

DOI: 10.5055/jom.0873 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Opioid Management, 2024. Verfasst von Mona Raafat Elghamry und 2 weiteren Autor:innen. Beteiligte Einrichtung: Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University, Tanta, Gharbia, Egypt. ORCID: https://orcid.org/0000-0002-7087-864X. Hauptthemen laut MEDLINE: Dexmedetomidine, Sleep Apnea, Obstructive, Analgesics, Opioid, Nerve Block. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study assessed the impact of erector spinae plane block (ESPB) and intravenous (IV) dexmedetomidine in reduction of perioperative opioid consumption following bariatric surgery and their impact on post-operative recovery, analgesia, and pulmonary functions.

Design

A randomized controlled trial.

Setting

Tanta University Hospitals, Tanta, Gharboa, Egypt. Patients: Forty obese patients with obstructive sleep apnea syndrome (OSAS), aged 20-55 years, and eligible for bariatric surgery were included.

Interventions

Patients randomized into group I (received general anesthesia [GA] with opioid, sham ESPB, and IV normal saline) or group II (received GA [without opioid], ESPB [at T7 level] using 20 mL bupivacaine 0.25 percent and bolus IV dexmedetomidine 1 μg/kg and then 0.25 μg/kg/h). Main outcome measures: Fentanyl consumption (primary outcome), sevoflurane consumption, recovery time, Visual Analog Scale (VAS), and pulmonary functions (secondary outcomes) were recorded.

Results

Perioperative fentanyl (intraoperative, post-operative, and total) consumption and sevoflurane consumption were substantially lower in group II compared to group I (p = 0.010,

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexmedetomidineSleep Apnea, ObstructiveAnalgesics, OpioidNerve BlockObesityPostoperative PainHumansMaleAdultMiddle AgedFemaleYoung AdultFentanylBariatric SurgeryEgyptParaspinal MusclesTreatment OutcomeDouble-Blind MethodAdministration, IntravenousPain Measurement

Substanzen

DexmedetomidineAnalgesics, OpioidFentanyl

Autor:innen und Institutionen

  • Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University, Tanta, Gharbia, Egypt. ORCID: https://orcid.org/0000-0002-7087-864X.
  • Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University, Tanta, Gharbia, Egypt. ORCID: https://orcid.org/0000-0002-2866-1295.
  • Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University, Tanta, Gharbia, Egypt. ORCID: https://orcid.org/0000-0002-7835-3653.

Zitieren

APA

Elghamry, M. R., Anwar, A. G., & Zahra, S. W. (2024). Opioid-sparing effect of erector spinae plane block and intravenous dexmedetomidine for obese patients with obstructive sleep apnea: A randomized controlled trial. Journal of Opioid Management. https://doi.org/10.5055/jom.0873

Vancouver

Elghamry MR, Anwar AG, Zahra SW. Opioid-sparing effect of erector spinae plane block and intravenous dexmedetomidine for obese patients with obstructive sleep apnea: A randomized controlled trial. Journal of Opioid Management. 2024. doi:10.5055/jom.0873

BibTeX
@article{Elghamry2024,
  author = {Elghamry, Mona Raafat and Anwar, Atteia Gad and Zahra, Shaimaa Waheed},
  title = {Opioid-sparing effect of erector spinae plane block and intravenous dexmedetomidine for obese patients with obstructive sleep apnea: A randomized controlled trial},
  journal = {Journal of Opioid Management},
  year = {2024},
  doi = {10.5055/jom.0873}
}
Kostenlos starten →